<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0186-4866</journal-id>
<journal-title><![CDATA[Medicina interna de México]]></journal-title>
<abbrev-journal-title><![CDATA[Med. interna Méx.]]></abbrev-journal-title>
<issn>0186-4866</issn>
<publisher>
<publisher-name><![CDATA[Edición y Farmacia S.A. de C.V.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0186-48662019000100020</article-id>
<article-id pub-id-type="doi">10.24245/mim.v35i1.2155</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Correlación entre concentraciones de ácido úrico y mortalidad hospitalaria en pacientes con evento vascular cerebral isquémico en un centro académico de alta especialidad]]></article-title>
<article-title xml:lang="en"><![CDATA[Correlation between uric acid levels and mortality in patients with ischemic cerebrovascular accident in an academic center]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Soto-Cossio]]></surname>
<given-names><![CDATA[Luz Estefhany]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Nieto]]></surname>
<given-names><![CDATA[Carlos Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Portales]]></surname>
<given-names><![CDATA[Jorge Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Mount Sinai Hospital Icahn School of Medicine ]]></institution>
<addr-line><![CDATA[New York NY]]></addr-line>
<country>USA</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Christus Muguerza Alta Especialidad  ]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Christus Muguerza Alta Especialidad  ]]></institution>
<addr-line><![CDATA[Monterrey Nuevo León]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2019</year>
</pub-date>
<volume>35</volume>
<numero>1</numero>
<fpage>20</fpage>
<lpage>29</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0186-48662019000100020&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0186-48662019000100020&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0186-48662019000100020&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  ANTECEDENTES:  El ácido úrico es un factor de riesgo independiente de enfermedades cardiovasculares y cerebrovasculares.  OBJETIVO: Analizar el papel del ácido úrico como factor pronóstico en el accidente cerebrovascular isquémico.  MATERIAL Y MÉTODO: Estudio de cohortes retrospectivo, efectuado en un hospital privado y académico. Se incluyeron pacientes con diagnóstico confirmado de evento vascular cerebral en el periodo de 2012 a 2016. Se clasificaron dos grupos: pacientes con hiperuricemia y sin hiperuricemia.  RESULTADOS: Se analizaron 202 pacientes, 59 (30%) con hiperuricemia y 143 (70%) sin hiperuricemia. En el análisis comparativo la mortalidad fue de 7.3% (n = 10) en pacientes sin hiperuricemia y de 5% (n = 3) en pacientes con hiperuricemia (p = 0.56). Se encontraron diferencias significativas en las concentraciones de glucosa (p = 0.02), creatinina (p = 0.004), colesterol (p = 0.028), ácido úrico (p &#8804; 0.0001) y triglicéridos (p = 0.014) entre ambas poblaciones. El análisis con regresión logística con corrección para potenciales de confusión no encontró asociación significativa entre la existencia de hiperuricemia al ingreso y la probabilidad de muerte (OR 2.098, IC95%: 0.47-9.332, p = 0.3304).  CONCLUSIÓN: Este estudio demuestra que en los pacientes hospitalizados con diagnóstico de evento cerebrovascular isquémico las concentraciones de ácido úrico o la hiperuricemia no se relacionan con incremento en la mortalidad intrahospitalaria.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  BACKGROUND: Elevations in serum uric acid levels are considered a risk factor for cardiovascular and cerebrovascular conditions.  OBJECTIVE: To analyze the relationship between high uric acid levels and the prognosis of patients with a cerebrovascular accident.  MATERIAL AND METHOD:  A retrospective cohort study performed at a single academic center. All patients with a confirmed diagnosis of cerebrovascular accident during the period between 2012 and 2016 were included in the analysis. Cohorts were segregated in patients with hyperuricemia and patients with normal serum uric acid levels.  RESULTS: Two hundred two patients with cerebrovascular accident were analyzed, 59 patients (30%) were diagnosed with hyperuricemia, 143 (70%) were used as a control group. On a comparative analysis, mortality rates were 7.3% (n = 10) on hyperuricemia group vs 5% (n = 3) in the control group (p = 0.056). Significant differences were found on serum cholesterol levels (p = 0.028), uric acid (p &#8804; 0.0001), glucose (p = 0.02), creatinine (p = 0.004) and triglycerides levels (p = 0.01) between cohorts. After controlling for potential confusing factors, there wasn&#8217;t found an association between the increase in serum uric acid levels and the odds of mortality (OR 2.098, IC95% 0.47-9.332, p = 0.3304).  CONCLUSIONS: This study demonstrates that inpatients diagnosed with a cerebrovascular accident mortality rates are not associated with hyperuricemia or increasing levels of serum uric acid.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Ácido úrico]]></kwd>
<kwd lng="es"><![CDATA[evento vascular cerebral]]></kwd>
<kwd lng="es"><![CDATA[hiperuricemia]]></kwd>
<kwd lng="en"><![CDATA[Uric acid]]></kwd>
<kwd lng="en"><![CDATA[Cerebrovascular accident]]></kwd>
<kwd lng="en"><![CDATA[Hyperuricemia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<source><![CDATA[Prevención secundaria, diagnóstico, tratamiento y vigilancia de la enfermedad vascular cerebral isquémica]]></source>
<year>2008</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Go]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Mozaffarian]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Roger]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heart disease and stroke statistics-2014 update a report from the American Heart Association]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2014</year>
<volume>129</volume>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cantú Brito]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo, causas y pronóstico de los tipos de enfermedad vascular cerebral en México Estudio RENAMEVASC]]></article-title>
<source><![CDATA[Rev Mex Neuroci]]></source>
<year>2011</year>
<volume>12</volume>
<page-range>224-34</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cantú Brito]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The first Mexican multicenter register on ischaemic stroke (the PREMIER study) demographics, risk factors and outcome]]></article-title>
<source><![CDATA[Int J Stroke]]></source>
<year>2011</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>93-4</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiquete Anaya]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Egresos por enfermedad vascular cerebral aguda en instituciones públicas del sector salud de México Un análisis de 5.3 millones de hospitalizaciones en 2010]]></article-title>
<source><![CDATA[Rev Mex Neuroci]]></source>
<year>2012</year>
<volume>13</volume>
<page-range>252-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feigin]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
<name>
<surname><![CDATA[Forouzanfar]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Krishnamurthi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global and regional burden of stroke in 1990-2010 Part 1: incidence, mortality, prevalence, and disability-adjusted life-year lost]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2014</year>
<volume>383</volume>
<numero>9913</numero>
<issue>9913</issue>
<page-range>218</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díez]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
<name>
<surname><![CDATA[Del Brutto]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abiusi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Classification of the cerebrovascular diseases]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2001</year>
<volume>33</volume>
<page-range>455-64</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiquete]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cantú]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
<name>
<surname><![CDATA[Villarreal]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Murillo]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Rangel]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity paradox and functional recovery in first-ever acute ischemic stroke survivors the PREMIER study]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2010</year>
<volume>51</volume>
<page-range>705-13</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Storhaug]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Norvik]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Eriksen]]></surname>
<given-names><![CDATA[BO]]></given-names>
</name>
<name>
<surname><![CDATA[Løchen]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Zykova]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study]]></article-title>
<source><![CDATA[BMC Cardiovasc Disord]]></source>
<year>2013</year>
<volume>11</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>115</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature]]></article-title>
<source><![CDATA[Neurol Sci]]></source>
<year>2015</year>
<volume>36</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1097-103</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naranjo]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Santana]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Pi]]></surname>
<given-names><![CDATA[OF]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa-Henríquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uricemia como factor pronóstico del ictus isquémico agudo]]></article-title>
<source><![CDATA[Neurología]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prasad]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum uric acid level in patients of acute stroke]]></article-title>
<source><![CDATA[Int J Adv Med]]></source>
<year>2017</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>393-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uaratanawong]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Suraamornkul]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Angkeaw]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Uaratanawong]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of hyperuricemia in Bangkok population]]></article-title>
<source><![CDATA[Clin Rheumatol]]></source>
<year>2011</year>
<volume>30</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>887-93</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moghaddam]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Iranmanesh]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Shafa]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Moghaddam]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Eslami]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum uric acid as an independent predictor of recurrence in ischemic stroke patients]]></article-title>
<source><![CDATA[Int Clin Neurosci J]]></source>
<year>2015</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>101-4</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonora]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relationship of uric acid concentration to cardiovascular risk factors in young men Role of obesity and central fat distribution. The Verona young men atherosclerosis risk factors study]]></article-title>
<source><![CDATA[Int J Obes Rel Metab Dis]]></source>
<year>1996</year>
<volume>20</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>975-80</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dehghan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Van]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Sijbrands]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hofman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Witteman]]></surname>
<given-names><![CDATA[JCM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High serum uric acid as a novel risk factor for type 2 diabetes]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2008</year>
<volume>31</volume>
<page-range>361-2</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weir]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Muir]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
<name>
<surname><![CDATA[Walters]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Lees]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2003</year>
<volume>34</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1951-6</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mozos]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Chiulana]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Goruna]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Costeab]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum uric acid in stroke]]></article-title>
<source><![CDATA[Ann West University of Timisoara, Series of Chemistry]]></source>
<year>2007</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>227-36</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abadal]]></surname>
<given-names><![CDATA[LT]]></given-names>
</name>
<name>
<surname><![CDATA[Vintró]]></surname>
<given-names><![CDATA[IB]]></given-names>
</name>
<name>
<surname><![CDATA[Puig]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Accidente vascular cerebral incidencia, mortalidad y factores de riesgo en 28 años de seguimiento. Estudio de Manresa]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2000</year>
<volume>53</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-20</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lamassa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe data from a multicenter multinational hospital-based registry. The European Community Stroke Project]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2001</year>
<volume>32</volume>
<page-range>392-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albers]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>1997</year>
<volume>48</volume>
<page-range>1598-604</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aisa]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Palma]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[WF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad vascular cerebral en el Hospital Ángeles Pedregal factores de riesgo cardiovascular y pronóstico hospitalario]]></article-title>
<source><![CDATA[Med Int Méx]]></source>
<year>2015</year>
<volume>31</volume>
<page-range>363-73</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Yilmaz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[YA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retrospective assessment of initial stroke severity with the NIH Stroke Scale]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2000</year>
<volume>31</volume>
<page-range>858-62</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seshadri]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The lifetime risk of stroke Estimates from the Framingham Study]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2006</year>
<volume>37</volume>
<page-range>345-50</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feigin]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2014</year>
<volume>383</volume>
<numero>9913</numero>
<issue>9913</issue>
<page-range>245-55</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum uric acid levels and outcomes after acute ischemic stroke]]></article-title>
<source><![CDATA[Mol Neurobiol]]></source>
<year>2016</year>
<volume>53</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1753-9</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krishnamurthi]]></surname>
<given-names><![CDATA[RV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global and regional burden of firstever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study]]></article-title>
<source><![CDATA[The Lancet Global Health]]></source>
<year>2010</year>
<volume>1</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>e259-81</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Haan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Limburg]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bossuyt]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Van der Meulen]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Aaronson]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The clinical meaning of Rankin 'handicap' grades after stroke]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>1995</year>
<volume>26</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2027-30</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[HP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Classification of subtype of acute ischemic stroke Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>1993</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-41</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Guevara]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
<name>
<surname><![CDATA[Heitjan]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Albert]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperuricemia and risk of stroke: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Arthritis Care &amp; Res]]></source>
<year>2009</year>
<volume>61</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>885-92</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiquete]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum uric acid and outcome after acute ischemic stroke PREMIER Study]]></article-title>
<source><![CDATA[Cerebrovasc Dis]]></source>
<year>2013</year>
<volume>35</volume>
<page-range>168-74</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yadav]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Nepal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Niroula]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of hyperuricemia among people of Morang district of Nepal]]></article-title>
<source><![CDATA[J Nobel Medical Coll]]></source>
<year>2014</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>16-21</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foerch]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ghandehari]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kaul]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exploring gender distribution in patients with acute stroke A multi-national approach]]></article-title>
<source><![CDATA[J Res Med Sci]]></source>
<year>2013</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El ácido úrico es un predictor de desarrollo de diabetes mellitus tipo 2 en la población general]]></article-title>
<source><![CDATA[Endocrinología y Nutrición]]></source>
<year>2009</year>
<volume>56</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>66-70</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<collab>NINDS t-PA Stroke Study Group</collab>
<article-title xml:lang=""><![CDATA[Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>1997</year>
<volume>28</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2109-18</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
